Lisinopril mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril Mechanism of Action: ACE Inhibition and Blood Pressure Control
Lisinopril is a long-acting, orally active angiotensin-converting enzyme (ACE) inhibitor. Its main mechanism is to block the conversion of angiotensin I to angiotensin II, a powerful vasoconstrictor, by competitively binding to ACE. This leads to vasodilation, which lowers blood pressure and reduces the workload on the heart 169. By decreasing angiotensin II levels, lisinopril also reduces aldosterone secretion from the adrenal cortex, resulting in increased sodium and water excretion 16.
Effects on the Renin-Angiotensin System and Cardiovascular Function
By inhibiting ACE, lisinopril reduces plasma angiotensin II and aldosterone, while increasing plasma renin activity. This results in a smooth, gradual reduction in both systolic and diastolic blood pressure without affecting heart rate or cardiovascular reflexes . Lisinopril also has natriuretic properties, helping to maintain or increase renal blood flow . In patients with heart failure, lisinopril increases cardiac output and decreases pulmonary capillary wedge pressure and mean arterial pressure .
Tissue-Specific ACE Inhibition
Lisinopril inhibits ACE activity in various tissues, including the kidney, adrenal gland, duodenum, lung, and certain regions of the brain. The degree of inhibition varies by tissue, and the effect can last for up to 24 hours after a single dose . This prolonged tissue ACE inhibition is thought to contribute to its blood pressure-lowering effects .
Cellular and Molecular Effects: Antioxidant and Anti-Inflammatory Actions
Lisinopril has been shown to protect heart cells from oxidative stress and fibrosis by upregulating antioxidant proteins such as catalase, SOD2, and thioredoxin, and by reducing fibrotic mediators like osteopontin and Galectin-3 . It also activates protective pathways involving Sirtuin 1 and Sirtuin 6 . In experimental models, lisinopril reduces the generation of reactive oxygen species (ROS) and suppresses proinflammatory immune cell activation, especially in the context of radiation-induced lung injury 2510. These effects are linked to its ability to block the ACE/angiotensin II/type 1 angiotensin receptor pathway, which is involved in inflammation and oxidative damage 2510.
Prevention of Cardiac Remodeling
Lisinopril and other ACE inhibitors can directly reduce the activity of matrix metalloproteinases (MMPs), particularly MMP-2, in the heart. This action helps prevent left ventricular dilation, myocardial hypertrophy, and negative changes in heart compliance and contractility, which are common in heart failure .
Neuroprotective and Additional Effects
Emerging research suggests that lisinopril may have neuroprotective effects by upregulating the ACE2/Ang1-7/MAS receptor axis, reducing inflammation, and improving mitochondrial function in models of neurodegenerative diseases . These findings indicate potential benefits beyond blood pressure control.
Conclusion
Lisinopril lowers blood pressure and protects the heart primarily by inhibiting ACE, which reduces angiotensin II and aldosterone levels, leading to vasodilation and increased sodium excretion. It also provides additional benefits by reducing oxidative stress, inflammation, and cardiac remodeling, and may have neuroprotective effects. These combined actions make lisinopril an effective and well-tolerated treatment for hypertension and heart failure 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic